Improving clinical trial access for non-English speakers
INcreasing CLinical Trial OpportUnities anD Enrollment of Non-English Speaking Research Subjects: A Revised Research Pathway (INCLUDE)
This study is looking at how to make clinical trials more welcoming for people who don't speak English, so everyone can have a fair chance to participate and benefit from new treatments.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mainehealth NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-11046220 on NIH RePORTER |
What this research studies
This research aims to address the significant underrepresentation of non-English speaking individuals in clinical trials, which leads to health inequities. It identifies barriers to enrollment, such as mistrust, logistical challenges, and regulatory complexities. By employing a modified Delphi method, the study seeks to gather insights from various stakeholders, including IRB members and community representatives, to develop best practices for overcoming these barriers. The ultimate goal is to create a more inclusive clinical trial environment that facilitates participation from diverse populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are non-English speaking individuals who may benefit from increased access to clinical trials.
Not a fit: Patients who are proficient in English or those who do not wish to participate in clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the representation of non-English speakers in clinical trials, leading to more equitable healthcare outcomes.
How similar studies have performed: While many studies have highlighted the barriers faced by non-English speakers in clinical trials, this research aims to propose and test novel solutions, making it a potentially groundbreaking approach.
Where this research is happening
Portland, United States
- Mainehealth — Portland, United States (Active)
Researchers
- Principal investigator: Chessa, Frank — Mainehealth
- Study coordinator: Chessa, Frank
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.